Volume 14; Issue 6

Main
The Lancet Oncology
Volume 14; Issue 6

The Lancet Oncology

Volume 14; Issue 6

1

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial

Waddell, Tom, Chau, Ian, Cunningham, David, Gonzalez, David, Okines, Alicia Frances Clare, Wotherspoon, Andrew, Saffery, Claire, Middleton, Gary, Wadsley, Jonathan, Ferry, David, Mansoor, Wasat, Crosb

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 396 KB

english, 2013

2

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

Lordick, Florian, Kang, Yoon-Koo, Chung, Hyun-Cheol, Salman, Pamela, Oh, Sang Cheul, Bodoky, György, Kurteva, Galina, Volovat, Constantin, Moiseyenko, Vladimir M, Gorbunova, Vera, Park, Joon Oh, Sawak

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 323 KB

english, 2013

3

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study

Swain, Sandra M, Kim, Sung-Bae, Cortés, Javier, Ro, Jungsil, Semiglazov, Vladimir, Campone, Mario, Ciruelos, Eva, Ferrero, Jean-Marc, Schneeweiss, Andreas, Knott, Adam, Clark, Emma, Ross, Graham, Beny

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 399 KB

english, 2013

4

Protein phosphatase 2A: a target for anticancer therapy

Perrotti, Danilo, Neviani, Paolo

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 288 KB

english, 2013

5

Cytokine patterns in patients with cancer: a systematic review

Lippitz, Bodo E

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 735 KB

english, 2013

6

Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study

Castelo-Branco, Pedro, Choufani, Sanaa, Mack, Stephen, Gallagher, Denis, Zhang, Cindy, Lipman, Tatiana, Zhukova, Nataliya, Walker, Erin J, Martin, Dianna, Merino, Diana, Wasserman, Jonathan D, Elizabe

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 1019 KB

english, 2013

7

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial

James, Roger D, Glynne-Jones, Robert, Meadows, Helen M, Cunningham, David, Myint, Arthur Sun, Saunders, Mark P, Maughan, Timothy, McDonald, Alec, Essapen, Sharadah, Leslie, Martin, Falk, Stephen, Wils

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 247 KB

english, 2013

8

Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial

Motzer, Robert J, Escudier, Bernard, Tomczak, Piotr, Hutson, Thomas E, Michaelson, M Dror, Negrier, Sylvie, Oudard, Stephane, Gore, Martin E, Tarazi, Jamal, Hariharan, Subramanian, Chen, Connie, Rosbr

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 316 KB

english, 2013

9

Relapsed childhood acute lymphoblastic leukaemia

Bhojwani, Deepa, Pui, Ching-Hon

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 466 KB

english, 2013

10

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

Mossé, Yael P, Lim, Megan S, Voss, Stephan D, Wilner, Keith, Ruffner, Katherine, Laliberte, Julie, Rolland, Delphine, Balis, Frank M, Maris, John M, Weigel, Brenda J, Ingle, Ashish M, Ahern, Charlotte

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 116 KB

english, 2013

11

Targeted therapy for gastric cancer

Fujita, Tetsuji

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 243 KB

english, 2013

12

Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis

DiSipio, Tracey, Rye, Sheree, Newman, Beth, Hayes, Sandi

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 269 KB

english, 2013

13

Has the time come for metronomics in low-income and middle-income countries?

André, Nicolas, Banavali, Shripad, Snihur, Yuliya, Pasquier, Eddy

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 246 KB

english, 2013

14

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial

Delarue, Richard, Tilly, Hervé, Mounier, Nicolas, Petrella, Tony, Salles, Gilles, Thieblemont, Catherine, Bologna, Serge, Ghesquières, Hervé, Hacini, Maya, Fruchart, Christophe, Ysebaert, Loïc, Fermé,

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 354 KB

english, 2013

15

Targeted treatments for breast cancer: a step forward

Bachelot, Thomas, Tredan, Olivier

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 321 KB

english, 2013

16

Arm lymphoedema after breast cancer

Mortimer, Peter

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 130 KB

english, 2013

17

Chocolate: delicious beauty or harmful beast?

Stebbing, Justin, Gajapathy, Venkatesh, Lowdell, Charles

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 1.34 MB

english, 2013

18

ACT II: treatment of anal cancer comes full circle

Willett, Christopher G, Czito, Brian G, Palta, Manisha

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 50 KB

english, 2013

19

Non-invasive ventilation for end-of-life oncology patients – Authors' reply

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 35 KB

english, 2013

20

Cuts to US Medicare disrupt chemotherapy services

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 93 KB

english, 2013

21

Diluted chemotherapy drugs affect 1200 patients in Canada

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 112 KB

english, 2013

22

HeLa

Ranscombe, Peter

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 120 KB

english, 2013

23

Love Is All You Need

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 361 KB

english, 2013

24

Regulating clinical trials in Europe

Willmott, Glenis

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 201 KB

english, 2013

25

Is India ready to lead the battle for fair access to medicines?

The Lancet Oncology,

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 135 KB

english, 2013

26

Radiotherapy capacity in Europe

Charalambous, Haris, Marcou, Yiola, Katodritis, Nicos, Kountourakis, Panteleimon, Andreopoulos, Demetris

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 34 KB

english, 2013

27

New agency to tackle cancer in Indigenous Australians

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 431 KB

english, 2013

28

New immune therapy shows success against B-cell ALL

Davies, Rachael

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 220 KB

english, 2013

29

TERT hypermethylation: biomarker in paediatric brain tumours

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 266 KB

english, 2013

30

Radiotherapy capacity in Europe – Authors' reply

Rosenblatt, Eduardo, Izewska, Joanna, Anacak, Yavuz, Pynda, Yaroslav, Scalliet, Pierre, Boniol, Mathieu, Autier, Philippe

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 46 KB

english, 2013

31

Cetuximab for liver metastases from colorectal cancer

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 184 KB

english, 2013

32

ALK-targeted therapy for poor-prognosis childhood cancers

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 150 KB

english, 2013

33

Patients would benefit from simplified ethical review and consent procedure

Hansson, Mats G, van Ommen, Gert Jan, Chadwick, Ruth, Dillner, Joakim

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 324 KB

english, 2013

34

Radiotherapy capacity in Europe

Grau, Cai, Borras, Josep M, Malicki, Julian, Slotman, Ben, Dunscombe, Peter, Coffey, Mary, Hollywood, Donal, Guedea, Ferran, Gasparotto, Chiara, Lievens, Yolande

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 55 KB

english, 2013

35

Radiation-free treatment for some lymphoma subtypes?

Sharma, Sharan Prakash

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 184 KB

english, 2013

36

CHOP intensification: not yet state of the art

Pfreundschuh, Michael

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 284 KB

english, 2013

37

Gene mutations linked to oesophageal adenocarcinoma

Burki, Talha Khan

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 220 KB

english, 2013

38

Non-invasive ventilation for end-of-life oncology patients

Azad, Arun, Franco, Michael

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 46 KB

english, 2013

39

Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study

Buikhuisen, Wieneke A, Burgers, Jacobus A, Vincent, Andrew D, Korse, Catharina M, van Klaveren, Rob J, Schramel, Franz MNH, Pavlakis, Nick, Nowak, Anna K, Custers, Frank LJ, Schouwink, J Hugo, Gans, S

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 363 KB

english, 2013

40

Mesothelioma: closer to the target?

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 129 KB

english, 2013

41

Non-invasive ventilation for end-of-life oncology patients

Azoulay, Elie, Kouatchet, Achille, Jaber, Samir, Meziani, Ferhat, Papazian, Laurent, Brochard, Laurent, Demoule, Alexandre

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 45 KB

english, 2013

42

Timing of hormone therapy for prostate cancer

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 112 KB

english, 2013

43

The need for proportionate regulation of clinical trials

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 111 KB

english, 2013

44

New options for second-line therapy of advanced renal cancer

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 290 KB

english, 2013

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Tor version

Z-Library

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски